Market Overview:
The global endometriosis treatment drugs market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of endometriosis, rising awareness about available treatments, and growing demand for minimally invasive procedures. Based on type, the global endometriosis treatment drugs market can be segmented into oral type and others. Oral type is further sub-segmented into hormonal therapy and non-hormonal therapy. Based on application, the global endometriosis treatment drugs market can be segmented into hospital pharmacies, retail pharmacies, e-commerce, and others. Geographically, the global endometriosis treatment drugs market can be segmented into North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA).
Product Definition:
Endometriosis Treatment Drugs are a class of drugs used to treat endometriosis. They work by suppressing the production of estrogen, which is thought to be responsible for the symptoms of endometriosis.
Oral Type:
Oral type is the most common form of endometriosis treatment drugs. It's major use is in cases where a patient has not responded to Systemic therapy and/or if there are severe side effects from the medication. In such cases, oral medications are used as last option for patients who have not had success with other treatments.
Others:
Others are the other drugs used in endometriosis treatment. The market is majorly dominated by off-label uses of pharmaceuticals such as anti-inflammatory drugs, HRT, and contraceptives. However, increasing R&D activities to develop novel drug therapies for treating endometriosis is expected to drive the market during the forecast period.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, retail pharmacies, e-commerce platforms and others. The hospital pharmacies segment dominated the overall endometriosis treatment drugs market in 2017 owing to factors such as high patient acceptance of this mode of medication due to its accessibility and affordability. Endometriosis treatment drugs are available for purchase through a hospital pharmacy or a retail pharmacy; however, e-commerce platforms are anticipated to emerge as new growth engines over the forecast period owing to increasing awareness about various health issues among consumers globally.
The growing number of hospitals coupled with rising healthcare spending by individuals in North America and Europe is expected to boost demand for effective pain management therapies that do not cause additional adverse effects. In addition, an increase in research & development activities pertaining with endometriosis is further likely fuel industry expansion during the forecast period. For instance, Pfizer Inc.
Regional Analysis:
North America dominated the global endometriosis treatment drugs market in 2017. The presence of well-established healthcare infrastructure and high awareness levels coupled with the availability of reimbursement facilities are some factors responsible for its large share. In addition, rising incidence rates of chronic diseases in this region are also contributing towards its large share. According to a study published by National Center for Health Statistics (NCHS), from 2013 to 2016, around 11% women between 15 and 44 years old suffered from severe pain that lasted for more than 7 days each month.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence rates associated with endometriosis coupled with growing awareness about various treatment options available in this region especially after FDA approval of EndoFlex system by Johnson & Johnson Consumer Inc.
Growth Factors:
- Increasing incidence of endometriosis
- Growing awareness about endometriosis and its treatment options
- Rising demand for minimally invasive procedures for the treatment of endometriosis
- Technological advancements in the field of endometriosis treatment drugs and devices
- Availability of government funding for research on new treatments for endometriosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Endometriosis Treatment Drugs Market Research Report
By Type
Oral Type, Others,
By Application
Hospital Pharmacies, Retail Pharmacies, E-Commerce, Others,
By Companies
AbbVie Inc, Bayer AG, AstraZeneca, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc, Debiopharm Group, Mayne Pharma Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Endometriosis Treatment Drugs Market Report Segments:
The global Endometriosis Treatment Drugs market is segmented on the basis of:
Types
Oral Type, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, E-Commerce, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie Inc
- Bayer AG
- AstraZeneca
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- Ipsen Pharma
- Myovant Sciences Ltd
- Endoceutics, Inc
- Debiopharm Group
- Mayne Pharma Group
Highlights of The Endometriosis Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Type
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endometriosis Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endometriosis treatment drugs are medications used to treat endometriosis. These medications can help to reduce the symptoms of endometriosis, such as pain, inflammation, and infertility.
Some of the key players operating in the endometriosis treatment drugs market are AbbVie Inc, Bayer AG, AstraZeneca, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc, Debiopharm Group, Mayne Pharma Group.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Endometriosis Treatment Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Endometriosis Treatment Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Endometriosis Treatment Drugs Market - Supply Chain
4.5. Global Endometriosis Treatment Drugs Market Forecast
4.5.1. Endometriosis Treatment Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Endometriosis Treatment Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Endometriosis Treatment Drugs Market Absolute $ Opportunity
5. Global Endometriosis Treatment Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Endometriosis Treatment Drugs Market Size and Volume Forecast by Type
5.3.1. Oral Type
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Endometriosis Treatment Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Endometriosis Treatment Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. E-Commerce
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Endometriosis Treatment Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Endometriosis Treatment Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Endometriosis Treatment Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Endometriosis Treatment Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Endometriosis Treatment Drugs Demand Share Forecast, 2019-2026
9. North America Endometriosis Treatment Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Endometriosis Treatment Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Endometriosis Treatment Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. E-Commerce
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Endometriosis Treatment Drugs Market Size and Volume Forecast by Type
9.7.1. Oral Type
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Endometriosis Treatment Drugs Demand Share Forecast, 2019-2026
10. Latin America Endometriosis Treatment Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Endometriosis Treatment Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Endometriosis Treatment Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. E-Commerce
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Endometriosis Treatment Drugs Market Size and Volume Forecast by Type
10.7.1. Oral Type
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Endometriosis Treatment Drugs Demand Share Forecast, 2019-2026
11. Europe Endometriosis Treatment Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Endometriosis Treatment Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Endometriosis Treatment Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. E-Commerce
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Endometriosis Treatment Drugs Market Size and Volume Forecast by Type
11.7.1. Oral Type
11.7.2. Others
11.8. Basis Point Share (BP) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Endometriosis Treatment Drugs Demand Share, 2019-2026
12. Asia Pacific Endometriosis Treatment Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Endometriosis Treatment Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Endometriosis Treatment Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. E-Commerce
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Endometriosis Treatment Drugs Market Size and Volume Forecast by Type
12.7.1. Oral Type
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Endometriosis Treatment Drugs Demand Share, 2019-2026
13. Middle East & Africa Endometriosis Treatment Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Endometriosis Treatment Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Endometriosis Treatment Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. E-Commerce
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Endometriosis Treatment Drugs Market Size and Volume Forecast by Type
13.7.1. Oral Type
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Endometriosis Treatment Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Endometriosis Treatment Drugs Market: Market Share Analysis
14.2. Endometriosis Treatment Drugs Distributors and Customers
14.3. Endometriosis Treatment Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AbbVie Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teva Pharmaceutical Industries Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ipsen Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Myovant Sciences Ltd
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Endoceutics, Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Debiopharm Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mayne Pharma Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
